Disease burden and treatment outcomes in second-line therapy of patients with estrogen receptor-positive advanced breast cancer: A review of the literature. The breast, Dec. 2012, Vol. 21(6), p.701-06.
Boswell, K.A., et al.
http://www.thebreastonline.com/article/PIIS0960977612001919/abstract?rss=yes
To determine the variable burden of disease of patients with advanced estrogen receptor-positive (ER+) breast cancer and assess the current treatment landscape after failure of first-line endocrine therapy.
